K-ras mutations in the duodenal fluid of patients with pancreatic carcinomaRobb E. Wilentz, Robbert J.C. Slebos, Patrick Sturm et al.|Cancer|1998Cited by 111
Clinical significance of K-ras oncogene activation in ampullary neoplasms.Christine H. Chung, Robbert J.C. Slebos, Robb E. Wilentz et al.|Journal of Clinical Pathology|1996Cited by 59
Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients.Ralph H. Hruban, G. J. A. Offerhaus, Patrick Sturm et al.|PubMed|1997Cited by 34
Screening for Pancreatic Cancer Using Techniques to Detect Altered Gene ProductsRobb E. Wilentz, Ralph H. Hruban, Robbert J.C. Slebos|Humana Press eBooks|1998Cited by 3